Global /Taiwan /Healthcare /Drug Manufacturers - General /7860

TEH SENG Pharmaceutical Mfg. Co., Ltd.

7860

• TPEX: 7860 • Delayed

61.40TWD 0%

1.94 USD

As of 6 June 2026, TEH SENG Pharmaceutical Mfg. Co., Ltd. has a market cap of $62.46M USD, ranking #28963 globally and #1695 in Taiwan. It ranks #2630 in the Healthcare sector, and #935 in the Drug Manufacturers - General industry.

Global Rank

28963

Country Rank

1695

Sector Rank

2630

Industry Rank

935

Key Stats

Market Cap

$62.46MUSD

1.96B TWD

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

340

Founded

1975

Website

tehseng.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-2.5%	-0.6%	-12%	-21%	-19%	-18%	-18%	-18%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	7860 ISIN: TW0007860009 TV: TradingView: TPEX: 7860 SA: Stock Analysis: TPEX: 7860 YF: Yahoo Finance: 7860.TWO GF: Google Finance: TPEX: 7860 BA: Barron's: 7860 MS: Morningstar: ROCO: 7860	61.40 TWD	TV: TradingView: TPEX: 7860 SA: Stock Analysis: TPEX: 7860 YF: Yahoo Finance: 7860.TWO GF: Google Finance: TPEX: 7860 BA: Barron's: 7860 MS: Morningstar: ROCO: 7860

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About TEH SENG Pharmaceutical Mfg. Co., Ltd.

TEH SENG Pharmaceutical Mfg. Co., Ltd. develops, manufactures, and sells pain relieving and cosmetic patches, and biotechnology products. It offers hydrogen patches, oil-based patches, hot-melt patches, transdermal patches, and oral film and sublingual films. The company also provides biocellulose facial masks, bio-rejuvenating facial treatment, skincare products, and daily supplements. It exports to Asia, Europe, and the United States. The company was founded in 1975 and is based in Tainan City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
PharmaEssentia Corp. TWSE: 6446	$7.8B 245.34B TWD 12K%	48.6	Taiwan
Lotus Pharmaceutical Co., Ltd. TWSE: 1795	$1.84B 57.95B TWD 3K%	12.2	Taiwan
Center Laboratories, Inc. TPEX: 4123	$925.55M 29.11B TWD 1K%	3.4	Taiwan
Lumosa Therapeutics Co., Ltd. TPEX: 6535	$809.3M 25.46B TWD 1K%	-	Taiwan
Oneness Biotech Co., Ltd. TPEX: 4743	$789.12M 24.82B TWD 1K%	-	Taiwan
TTY Biopharm Company Ltd. TPEX: 4105	$584.14M 18.38B TWD 835%	11.8	Taiwan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 876K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 577K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 520K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 463K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 444K%	20.5	Switzerland

chevron_leftBack